ESSA Pharma Valuation
| EPIXDelisted Stock | USD 0.20 0.00 0.00% |
ESSA Pharma seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of ESSA Pharma from evaluating the firm fundamentals such as Return On Asset of -0.15, shares owned by insiders of 5.61 %, and Current Valuation of (99.33 M) as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ESSA Pharma's price fluctuation is very steady at this time. Calculation of the real value of ESSA Pharma is based on 3 months time horizon. Increasing ESSA Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ESSA Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ESSA Stock. However, ESSA Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.2 | Real 0.19 | Hype 0.2 |
The intrinsic value of ESSA Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ESSA Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ESSA Pharma helps investors to forecast how ESSA stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ESSA Pharma more accurately as focusing exclusively on ESSA Pharma's fundamentals will not take into account other important factors: About ESSA Pharma Valuation
Our relative valuation model uses a comparative analysis of ESSA Pharma. We calculate exposure to ESSA Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ESSA Pharma's related companies.ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada. Essa Pharma is traded on NASDAQ Exchange in the United States.
A single share of ESSA Pharma represents a small ownership stake in the entity. As a stockholder of ESSA, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
ESSA Pharma Dividends Analysis For Valuation
Please note that ESSA Pharma has scaled down on payment of dividends at this time.
There are various types of dividends ESSA Pharma can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of ESSA shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from ESSA Pharma directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When ESSA pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of ESSA Pharma by the value of the dividends paid out.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in ESSA Stock
If you are still planning to invest in ESSA Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ESSA Pharma's history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |